Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8994797rdf:typepubmed:Citationlld:pubmed
pubmed-article:8994797lifeskim:mentionsumls-concept:C0449911lld:lifeskim
pubmed-article:8994797lifeskim:mentionsumls-concept:C0949285lld:lifeskim
pubmed-article:8994797lifeskim:mentionsumls-concept:C0013185lld:lifeskim
pubmed-article:8994797lifeskim:mentionsumls-concept:C0683966lld:lifeskim
pubmed-article:8994797pubmed:dateCreated1997-3-19lld:pubmed
pubmed-article:8994797pubmed:abstractTextThe development of new antibiotics has been successful in significantly reducing morbidity and mortality. With increasing use there has occurred an increase in antibiotic resistance but not a parallel increase in new agents with significantly improved spectrum of activity. Without concerted action from the pharmaceutical industry, physicians, academia, health care providers, and governments, the prospects look gloomy.lld:pubmed
pubmed-article:8994797pubmed:languageenglld:pubmed
pubmed-article:8994797pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8994797pubmed:citationSubsetIMlld:pubmed
pubmed-article:8994797pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8994797pubmed:statusMEDLINElld:pubmed
pubmed-article:8994797pubmed:monthJanlld:pubmed
pubmed-article:8994797pubmed:issn1058-4838lld:pubmed
pubmed-article:8994797pubmed:authorpubmed-author:DayP WPWlld:pubmed
pubmed-article:8994797pubmed:issnTypePrintlld:pubmed
pubmed-article:8994797pubmed:volume24 Suppl 1lld:pubmed
pubmed-article:8994797pubmed:ownerNLMlld:pubmed
pubmed-article:8994797pubmed:authorsCompleteYlld:pubmed
pubmed-article:8994797pubmed:paginationS151-3lld:pubmed
pubmed-article:8994797pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:8994797pubmed:meshHeadingpubmed-meshheading:8994797-...lld:pubmed
pubmed-article:8994797pubmed:meshHeadingpubmed-meshheading:8994797-...lld:pubmed
pubmed-article:8994797pubmed:meshHeadingpubmed-meshheading:8994797-...lld:pubmed
pubmed-article:8994797pubmed:meshHeadingpubmed-meshheading:8994797-...lld:pubmed
pubmed-article:8994797pubmed:meshHeadingpubmed-meshheading:8994797-...lld:pubmed
pubmed-article:8994797pubmed:meshHeadingpubmed-meshheading:8994797-...lld:pubmed
pubmed-article:8994797pubmed:year1997lld:pubmed
pubmed-article:8994797pubmed:articleTitleAntibiotic resistance: a view from the pharmaceutical industry.lld:pubmed
pubmed-article:8994797pubmed:affiliationDepartment of Clinical Research and Development, SmithKline Beecham Pharmaceuticals, Harlow, Essex, England.lld:pubmed
pubmed-article:8994797pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8994797lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8994797lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8994797lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8994797lld:pubmed